You are here

Protagnosit Therapeutics

Twist in Protagonist story as FDA seeks to rescind breakthrough nod 'based on observed malignancies'

Fierce Biotech

Thu, 04/14/22 - 10:47 am

Protagnosit Therapeutics

breakthrough designation